Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Security

Mineralys Therapeutics, Inc. Common Stock · MLYS

MLYSNASDAQCommon stockCurrentCIK 1933414Updated Nov 6, 2026

Company: Mineralys Therapeutics, Inc. →

MLYS price & chart

Provider market data

Loading TradingView…

NASDAQ:MLYS on TradingView ↗

TradingView · Data may be delayed

About the company

Mineralys Therapeutics is a biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease, obstructive sleep apnea and other diseases driven by dysregulated aldosterone. Its initial product candidate, lorundrostat, is an investigational, proprietary, orally administered, highly selective aldosterone synthase inhibitor. Mineralys is based in Radnor, Pennsylvania, and was founded by Catalys Pacific. For more information, please visit https://mineralystx.com. Follow Mineralys on LinkedIn, X and Bluesky.

8-K · 2026-11-04 · 0001933414-26-000142

Company description from the cited filing.

In the news

Seeking Alpha

Financials

FY 2025 · USD
Revenue— · FY 2025
Net income-154,651,000USD · FY 2025
Source

10-K · 2026-03-12 · 0001933414-26-000056

2025-01-01 to 2025-12-31

Operating income-170,604,000USD · FY 2025
Source

10-K · 2026-03-12 · 0001933414-26-000056

2025-01-01 to 2025-12-31

Diluted EPS-2.29USD per share · FY 2025
Source

10-K · 2026-03-12 · 0001933414-26-000056

2025-01-01 to 2025-12-31

Some figures are unavailable for this reporting year.

balance sheet · annual statements
Line itemQ3 2025Q3 2024Q2 2026Q2 2025Q2 2024Q1 2026Q1 2025Q1 2024FY 2025FY 2024FY 2023FY 2022
ASSETS
AssetsUSD599,947,000
Source

10-Q · 2025-11-10 · 0001933414-25-000142

As of 2025-09-30

268,253,000
Source

10-Q · 2024-11-12 · 0001933414-24-000057

As of 2024-09-30

667,853,000
Source

10-Q · 2026-08-11 · 0001933414-26-000114

As of 2026-06-30

335,724,000
Source

10-Q · 2025-08-12 · 0001933414-25-000090

As of 2025-06-30

318,492,000
Source

10-Q · 2024-08-13 · 0001933414-24-000039

As of 2024-06-30

652,862,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

As of 2026-03-31

354,941,000
Source

10-Q · 2025-05-12 · 0001933414-25-000058

As of 2025-03-31

347,249,000
Source

10-Q · 2024-05-09 · 0001933414-24-000016

As of 2024-03-31

661,806,000
Source

10-K · 2026-03-12 · 0001933414-26-000056

As of 2025-12-31

205,903,000
Source

10-K · 2025-02-12 · 0001933414-25-000009

As of 2024-12-31

251,636,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

As of 2023-12-31

114,442,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

As of 2022-12-31

Property, Plant and Equipment, NetUSD7,000
Source

10-Q · 2025-11-10 · 0001933414-25-000142

As of 2025-09-30

69,000
Source

10-Q · 2024-11-12 · 0001933414-24-000057

As of 2024-09-30

27,000
Source

10-Q · 2026-08-11 · 0001933414-26-000114

As of 2026-06-30

22,000
Source

10-Q · 2025-08-12 · 0001933414-25-000090

As of 2025-06-30

42,000
Source

10-Q · 2024-08-13 · 0001933414-24-000039

As of 2024-06-30

32,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

As of 2026-03-31

38,000
Source

10-Q · 2025-05-12 · 0001933414-25-000058

As of 2025-03-31

51,000
Source

10-Q · 2024-05-09 · 0001933414-24-000016

As of 2024-03-31

38,000
Source

10-K · 2026-03-12 · 0001933414-26-000056

As of 2025-12-31

53,000
Source

10-K · 2025-02-12 · 0001933414-25-000009

As of 2024-12-31

——
Current assets:
Cash and Cash Equivalents, at Carrying ValueUSD217,597,000
Source

10-Q · 2025-11-10 · 0001933414-25-000142

As of 2025-09-30

97,274,000
Source

10-Q · 2024-11-12 · 0001933414-24-000057

As of 2024-09-30

138,268,000
Source

10-Q · 2026-08-11 · 0001933414-26-000114

As of 2026-06-30

101,788,000
Source

10-Q · 2025-08-12 · 0001933414-25-000090

As of 2025-06-30

67,856,000
Source

10-Q · 2024-08-13 · 0001933414-24-000039

As of 2024-06-30

112,779,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

As of 2026-03-31

165,007,000
Source

10-Q · 2025-05-12 · 0001933414-25-000058

As of 2025-03-31

90,418,000
Source

10-Q · 2024-05-09 · 0001933414-24-000016

As of 2024-03-31

172,921,000
Source

10-K · 2026-03-12 · 0001933414-26-000056

As of 2025-12-31

114,091,000
Source

10-K · 2025-02-12 · 0001933414-25-000009

As of 2024-12-31

49,304,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

As of 2023-12-31

87,701,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

As of 2022-12-31

Assets, CurrentUSD599,796,000
Source

10-Q · 2025-11-10 · 0001933414-25-000142

As of 2025-09-30

267,732,000
Source

10-Q · 2024-11-12 · 0001933414-24-000057

As of 2024-09-30

665,802,000
Source

10-Q · 2026-08-11 · 0001933414-26-000114

As of 2026-06-30

335,269,000
Source

10-Q · 2025-08-12 · 0001933414-25-000090

As of 2025-06-30

318,001,000
Source

10-Q · 2024-08-13 · 0001933414-24-000039

As of 2024-06-30

652,470,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

As of 2026-03-31

354,506,000
Source

10-Q · 2025-05-12 · 0001933414-25-000058

As of 2025-03-31

346,819,000
Source

10-Q · 2024-05-09 · 0001933414-24-000016

As of 2024-03-31

661,386,000
Source

10-K · 2026-03-12 · 0001933414-26-000056

As of 2025-12-31

205,351,000
Source

10-K · 2025-02-12 · 0001933414-25-000009

As of 2024-12-31

249,103,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

As of 2023-12-31

112,811,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

As of 2022-12-31

Prepaid Expense and Other Assets, CurrentUSD6,168,000
Source

10-Q · 2025-11-10 · 0001933414-25-000142

As of 2025-09-30

4,129,000
Source

10-Q · 2024-11-12 · 0001933414-24-000057

As of 2024-09-30

4,390,000
Source

10-Q · 2026-08-11 · 0001933414-26-000114

As of 2026-06-30

10,353,000
Source

10-Q · 2025-08-12 · 0001933414-25-000090

As of 2025-06-30

6,886,000
Source

10-Q · 2024-08-13 · 0001933414-24-000039

As of 2024-06-30

6,410,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

As of 2026-03-31

11,480,000
Source

10-Q · 2025-05-12 · 0001933414-25-000058

As of 2025-03-31

8,254,000
Source

10-Q · 2024-05-09 · 0001933414-24-000016

As of 2024-03-31

4,751,000
Source

10-K · 2026-03-12 · 0001933414-26-000056

As of 2025-12-31

7,164,000
Source

10-K · 2025-02-12 · 0001933414-25-000009

As of 2024-12-31

12,536,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

As of 2023-12-31

2,701,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

As of 2022-12-31

Other Assets, NoncurrentUSD144,000
Source

10-Q · 2025-11-10 · 0001933414-25-000142

As of 2025-09-30

452,000
Source

10-Q · 2024-11-12 · 0001933414-24-000057

As of 2024-09-30

2,024,000
Source

10-Q · 2026-08-11 · 0001933414-26-000114

As of 2026-06-30

433,000
Source

10-Q · 2025-08-12 · 0001933414-25-000090

As of 2025-06-30

449,000
Source

10-Q · 2024-08-13 · 0001933414-24-000039

As of 2024-06-30

360,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

As of 2026-03-31

397,000
Source

10-Q · 2025-05-12 · 0001933414-25-000058

As of 2025-03-31

379,000
Source

10-Q · 2024-05-09 · 0001933414-24-000016

As of 2024-03-31

382,000
Source

10-K · 2026-03-12 · 0001933414-26-000056

As of 2025-12-31

499,000
Source

10-K · 2025-02-12 · 0001933414-25-000009

As of 2024-12-31

51,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

As of 2023-12-31

1,631,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

As of 2022-12-31

LIABILITIES AND EQUITY
Stockholders’ equity:
Common Stock, Value, IssuedUSD8,000
Source

10-Q · 2025-11-10 · 0001933414-25-000142

As of 2025-09-30

5,000
Source

10-Q · 2024-11-12 · 0001933414-24-000057

As of 2024-09-30

9,000
Source

10-Q · 2026-08-11 · 0001933414-26-000114

As of 2026-06-30

6,000
Source

10-Q · 2025-08-12 · 0001933414-25-000090

As of 2025-06-30

5,000
Source

10-Q · 2024-08-13 · 0001933414-24-000039

As of 2024-06-30

8,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

As of 2026-03-31

6,000
Source

10-Q · 2025-05-12 · 0001933414-25-000058

As of 2025-03-31

5,000
Source

10-Q · 2024-05-09 · 0001933414-24-000016

As of 2024-03-31

8,000
Source

10-K · 2026-03-12 · 0001933414-26-000056

As of 2025-12-31

5,000
Source

10-K · 2025-02-12 · 0001933414-25-000009

As of 2024-12-31

4,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

As of 2023-12-31

1,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

As of 2022-12-31

Additional Paid in CapitalUSD1,001,354,000
Source

10-Q · 2025-11-10 · 0001933414-25-000142

As of 2025-09-30

490,499,000
Source

10-Q · 2024-11-12 · 0001933414-24-000057

As of 2024-09-30

1,288,487,000
Source

10-Q · 2026-08-11 · 0001933414-26-000114

As of 2026-06-30

701,548,000
Source

10-Q · 2025-08-12 · 0001933414-25-000090

As of 2025-06-30

487,320,000
Source

10-Q · 2024-08-13 · 0001933414-24-000039

As of 2024-06-30

1,134,644,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

As of 2026-03-31

686,278,000
Source

10-Q · 2025-05-12 · 0001933414-25-000058

As of 2025-03-31

484,256,000
Source

10-Q · 2024-05-09 · 0001933414-24-000016

As of 2024-03-31

1,103,854,000
Source

10-K · 2026-03-12 · 0001933414-26-000056

As of 2025-12-31

493,770,000
Source

10-K · 2025-02-12 · 0001933414-25-000009

As of 2024-12-31

365,858,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

As of 2023-12-31

540,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

As of 2022-12-31

Retained Earnings (Accumulated Deficit)USD-424,935,000
Source

10-Q · 2025-11-10 · 0001933414-25-000142

As of 2025-09-30

-253,572,000
Source

10-Q · 2024-11-12 · 0001933414-24-000057

As of 2024-09-30

-737,579,000
Source

10-Q · 2026-08-11 · 0001933414-26-000114

As of 2026-06-30

-388,003,000
Source

10-Q · 2025-08-12 · 0001933414-25-000090

As of 2025-06-30

-197,230,000
Source

10-Q · 2024-08-13 · 0001933414-24-000039

As of 2024-06-30

-496,508,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

As of 2026-03-31

-344,729,000
Source

10-Q · 2025-05-12 · 0001933414-25-000058

As of 2025-03-31

-156,216,000
Source

10-Q · 2024-05-09 · 0001933414-24-000016

As of 2024-03-31

-457,169,000
Source

10-K · 2026-03-12 · 0001933414-26-000056

As of 2025-12-31

-302,518,000
Source

10-K · 2025-02-12 · 0001933414-25-000009

As of 2024-12-31

-124,708,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

As of 2023-12-31

-52,810,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

As of 2022-12-31

Stockholders' Equity Attributable to ParentUSD576,427,000
Source

10-Q · 2025-11-10 · 0001933414-25-000142

As of 2025-09-30

236,932,000
Source

10-Q · 2025-11-10 · 0001933414-25-000142

As of 2024-09-30

550,917,000
Source

10-Q · 2026-08-11 · 0001933414-26-000114

As of 2026-06-30

313,551,000
Source

10-Q · 2026-08-11 · 0001933414-26-000114

As of 2025-06-30

290,095,000
Source

10-Q · 2025-08-12 · 0001933414-25-000090

As of 2024-06-30

638,144,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

As of 2026-03-31

341,555,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

As of 2025-03-31

328,045,000
Source

10-Q · 2025-05-12 · 0001933414-25-000058

As of 2024-03-31

646,693,000
Source

10-K · 2026-03-12 · 0001933414-26-000056

As of 2025-12-31

191,257,000
Source

10-K · 2025-02-12 · 0001933414-25-000009

As of 2024-12-31

241,154,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

As of 2023-12-31

-52,269,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

As of 2022-12-31

Liabilities and EquityUSD599,947,000
Source

10-Q · 2025-11-10 · 0001933414-25-000142

As of 2025-09-30

268,253,000
Source

10-Q · 2024-11-12 · 0001933414-24-000057

As of 2024-09-30

667,853,000
Source

10-Q · 2026-08-11 · 0001933414-26-000114

As of 2026-06-30

335,724,000
Source

10-Q · 2025-08-12 · 0001933414-25-000090

As of 2025-06-30

318,492,000
Source

10-Q · 2024-08-13 · 0001933414-24-000039

As of 2024-06-30

652,862,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

As of 2026-03-31

354,941,000
Source

10-Q · 2025-05-12 · 0001933414-25-000058

As of 2025-03-31

347,249,000
Source

10-Q · 2024-05-09 · 0001933414-24-000016

As of 2024-03-31

661,806,000
Source

10-K · 2026-03-12 · 0001933414-26-000056

As of 2025-12-31

205,903,000
Source

10-K · 2025-02-12 · 0001933414-25-000009

As of 2024-12-31

251,636,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

As of 2023-12-31

114,442,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

As of 2022-12-31

Current liabilities:
Liabilities, CurrentUSD23,520,000
Source

10-Q · 2025-11-10 · 0001933414-25-000142

As of 2025-09-30

31,321,000
Source

10-Q · 2024-11-12 · 0001933414-24-000057

As of 2024-09-30

19,319,000
Source

10-Q · 2026-08-11 · 0001933414-26-000114

As of 2026-06-30

22,173,000
Source

10-Q · 2025-08-12 · 0001933414-25-000090

As of 2025-06-30

28,397,000
Source

10-Q · 2024-08-13 · 0001933414-24-000039

As of 2024-06-30

14,718,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

As of 2026-03-31

13,386,000
Source

10-Q · 2025-05-12 · 0001933414-25-000058

As of 2025-03-31

19,204,000
Source

10-Q · 2024-05-09 · 0001933414-24-000016

As of 2024-03-31

15,113,000
Source

10-K · 2026-03-12 · 0001933414-26-000056

As of 2025-12-31

14,646,000
Source

10-K · 2025-02-12 · 0001933414-25-000009

As of 2024-12-31

10,482,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

As of 2023-12-31

8,067,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

As of 2022-12-31

Accounts Payable, CurrentUSD1,121,000
Source

10-Q · 2025-11-10 · 0001933414-25-000142

As of 2025-09-30

3,106,000
Source

10-Q · 2024-11-12 · 0001933414-24-000057

As of 2024-09-30

1,066,000
Source

10-Q · 2026-08-11 · 0001933414-26-000114

As of 2026-06-30

3,164,000
Source

10-Q · 2025-08-12 · 0001933414-25-000090

As of 2025-06-30

1,707,000
Source

10-Q · 2024-08-13 · 0001933414-24-000039

As of 2024-06-30

1,116,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

As of 2026-03-31

373,000
Source

10-Q · 2025-05-12 · 0001933414-25-000058

As of 2025-03-31

4,261,000
Source

10-Q · 2024-05-09 · 0001933414-24-000016

As of 2024-03-31

2,017,000
Source

10-K · 2026-03-12 · 0001933414-26-000056

As of 2025-12-31

479,000
Source

10-K · 2025-02-12 · 0001933414-25-000009

As of 2024-12-31

601,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

As of 2023-12-31

1,907,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

As of 2022-12-31

Additional Financial Items
Accrued Liabilities, CurrentUSD22,399,000
Source

10-Q · 2025-11-10 · 0001933414-25-000142

As of 2025-09-30

28,215,000
Source

10-Q · 2024-11-12 · 0001933414-24-000057

As of 2024-09-30

18,253,000
Source

10-Q · 2026-08-11 · 0001933414-26-000114

As of 2026-06-30

19,009,000
Source

10-Q · 2025-08-12 · 0001933414-25-000090

As of 2025-06-30

26,690,000
Source

10-Q · 2024-08-13 · 0001933414-24-000039

As of 2024-06-30

13,602,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

As of 2026-03-31

13,013,000
Source

10-Q · 2025-05-12 · 0001933414-25-000058

As of 2025-03-31

14,943,000
Source

10-Q · 2024-05-09 · 0001933414-24-000016

As of 2024-03-31

13,096,000
Source

10-K · 2026-03-12 · 0001933414-26-000056

As of 2025-12-31

14,167,000
Source

10-K · 2025-02-12 · 0001933414-25-000009

As of 2024-12-31

9,881,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

As of 2023-12-31

6,160,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

As of 2022-12-31

Liabilities———
Source

10-Q · 2026-08-11 · 0001933414-26-000114

As of 2026-06-30

—————————
Long-term Debt———
Source

10-Q · 2026-08-11 · 0001933414-26-000114

As of 2026-06-30

—————————

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements
Line itemQ4 2025Q4 2024Q3 2025Q3 2024Q2 2026Q2 2025Q1 2026Q1 2025FY 2025FY 2024FY 2023FY 2022
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, Depletion and AmortizationUSD——————6,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2026-01-01 to 2026-03-31

15,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2025-01-01 to 2025-03-31

59,000
Source

10-K · 2026-03-12 · 0001933414-26-000056

2025-01-01 to 2025-12-31

43,000
Source

10-K · 2025-02-12 · 0001933414-25-000009

2024-01-01 to 2024-12-31

——
Share-based Payment Arrangement, Noncash ExpenseUSD——————6,548,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2026-01-01 to 2026-03-31

3,645,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2025-01-01 to 2025-03-31

19,324,000
Source

10-K · 2026-03-12 · 0001933414-26-000056

2025-01-01 to 2025-12-31

11,336,000
Source

10-K · 2025-02-12 · 0001933414-25-000009

2024-01-01 to 2024-12-31

5,060,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

2023-01-01 to 2023-12-31

455,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

2022-01-01 to 2022-12-31

Deferred Income Tax Expense (Benefit)USD————————0
Source

10-K · 2026-03-12 · 0001933414-26-000056

2025-01-01 to 2025-12-31

0
Source

10-K · 2025-02-12 · 0001933414-25-000009

2024-01-01 to 2024-12-31

0
Source

10-K · 2024-03-21 · 0001628280-24-012358

2023-01-01 to 2023-12-31

0
Source

10-K · 2024-03-21 · 0001628280-24-012358

2022-01-01 to 2022-12-31

Net Cash Provided by (Used in) Operating ActivitiesUSD——————-39,471,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2026-01-01 to 2026-03-31

-45,487,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2025-01-01 to 2025-03-31

-142,416,000
Source

10-K · 2026-03-12 · 0001933414-26-000056

2025-01-01 to 2025-12-31

-166,314,000
Source

10-K · 2025-02-12 · 0001933414-25-000009

2024-01-01 to 2024-12-31

-81,173,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

2023-01-01 to 2023-12-31

-29,221,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

2022-01-01 to 2022-12-31

Cash flows from investing activities:
Net Cash Provided by (Used in) Investing ActivitiesUSD——————-44,943,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2026-01-01 to 2026-03-31

-92,876,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2025-01-01 to 2025-03-31

-389,753,000
Source

10-K · 2026-03-12 · 0001933414-26-000056

2025-01-01 to 2025-12-31

114,959,000
Source

10-K · 2025-02-12 · 0001933414-25-000009

2024-01-01 to 2024-12-31

-160,472,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

2023-01-01 to 2023-12-31

-21,759,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

2022-01-01 to 2022-12-31

Cash flows from financing activities:
Net Cash Provided by (Used in) Financing ActivitiesUSD——————24,272,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2026-01-01 to 2026-03-31

189,279,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2025-01-01 to 2025-03-31

590,999,000
Source

10-K · 2026-03-12 · 0001933414-26-000056

2025-01-01 to 2025-12-31

116,142,000
Source

10-K · 2025-02-12 · 0001933414-25-000009

2024-01-01 to 2024-12-31

203,248,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

2023-01-01 to 2023-12-31

128,019,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

2022-01-01 to 2022-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD——————-60,142,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2026-01-01 to 2026-03-31

50,916,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2025-01-01 to 2025-03-31

58,830,000
Source

10-K · 2026-03-12 · 0001933414-26-000056

2025-01-01 to 2025-12-31

64,787,000
Source

10-K · 2025-02-12 · 0001933414-25-000009

2024-01-01 to 2024-12-31

-38,397,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

2023-01-01 to 2023-12-31

77,039,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

2022-01-01 to 2022-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD——217,597,000
Source

10-Q · 2025-11-10 · 0001933414-25-000142

As of 2025-09-30

97,274,000
Source

10-Q · 2025-11-10 · 0001933414-25-000142

As of 2024-09-30

138,268,000
Source

10-Q · 2026-08-11 · 0001933414-26-000114

As of 2026-06-30

101,788,000
Source

10-Q · 2026-08-11 · 0001933414-26-000114

As of 2025-06-30

112,779,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

As of 2026-03-31

165,007,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

As of 2025-03-31

172,921,000
Source

10-K · 2026-03-12 · 0001933414-26-000056

As of 2025-12-31

114,091,000
Source

10-K · 2025-02-12 · 0001933414-25-000009

As of 2024-12-31

49,304,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

As of 2023-12-31

87,701,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

As of 2022-12-31

Additional Financial Items
Share-based Payment Arrangement, ExpenseUSD——5,841,000
Source

10-Q · 2025-11-10 · 0001933414-25-000142

2025-07-01 to 2025-09-30

3,139,000
Source

10-Q · 2025-11-10 · 0001933414-25-000142

2024-07-01 to 2024-09-30

7,355,000
Source

10-Q · 2026-08-11 · 0001933414-26-000114

2026-04-01 to 2026-06-30

4,553,000
Source

10-Q · 2026-08-11 · 0001933414-26-000114

2025-04-01 to 2025-06-30

6,548,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2026-01-01 to 2026-03-31

3,645,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2025-01-01 to 2025-03-31

19,324,000
Source

10-K · 2026-03-12 · 0001933414-26-000056

2025-01-01 to 2025-12-31

11,336,000
Source

10-K · 2025-02-12 · 0001933414-25-000009

2024-01-01 to 2024-12-31

5,060,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

2023-01-01 to 2023-12-31

455,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

2022-01-01 to 2022-12-31

General and Administrative ExpenseUSD——9,681,000
Source

10-Q · 2025-11-10 · 0001933414-25-000142

2025-07-01 to 2025-09-30

6,121,000
Source

10-Q · 2025-11-10 · 0001933414-25-000142

2024-07-01 to 2024-09-30

24,663,000
Source

10-Q · 2026-08-11 · 0001933414-26-000114

2026-04-01 to 2026-06-30

8,468,000
Source

10-Q · 2026-08-11 · 0001933414-26-000114

2025-04-01 to 2025-06-30

20,975,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2026-01-01 to 2026-03-31

6,568,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2025-01-01 to 2025-03-31

38,595,000
Source

10-K · 2026-03-12 · 0001933414-26-000056

2025-01-01 to 2025-12-31

23,822,000
Source

10-K · 2025-02-12 · 0001933414-25-000009

2024-01-01 to 2024-12-31

14,296,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

2023-01-01 to 2023-12-31

5,229,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

2022-01-01 to 2022-12-31

Income Tax Expense (Benefit)USD————————0
Source

10-K · 2026-03-12 · 0001933414-26-000056

2025-01-01 to 2025-12-31

———
Net Income (Loss) Attributable to ParentUSD——-36,932,000
Source

10-Q · 2025-11-10 · 0001933414-25-000142

2025-07-01 to 2025-09-30

-56,342,000
Source

10-Q · 2025-11-10 · 0001933414-25-000142

2024-07-01 to 2024-09-30

-241,071,000
Source

10-Q · 2026-08-11 · 0001933414-26-000114

2026-04-01 to 2026-06-30

-43,274,000
Source

10-Q · 2026-08-11 · 0001933414-26-000114

2025-04-01 to 2025-06-30

-39,339,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2026-01-01 to 2026-03-31

-42,211,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2025-01-01 to 2025-03-31

-154,651,000
Source

10-K · 2026-03-12 · 0001933414-26-000056

2025-01-01 to 2025-12-31

-177,810,000
Source

10-K · 2025-02-12 · 0001933414-25-000009

2024-01-01 to 2024-12-31

-71,898,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

2023-01-01 to 2023-12-31

-29,799,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

2022-01-01 to 2022-12-31

Nonoperating Income (Expense)USD——4,199,000
Source

10-Q · 2025-11-10 · 0001933414-25-000142

2025-07-01 to 2025-09-30

3,764,000
Source

10-Q · 2025-11-10 · 0001933414-25-000142

2024-07-01 to 2024-09-30

4,969,000
Source

10-Q · 2026-08-11 · 0001933414-26-000114

2026-04-01 to 2026-06-30

3,472,000
Source

10-Q · 2026-08-11 · 0001933414-26-000114

2025-04-01 to 2025-06-30

6,001,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2026-01-01 to 2026-03-31

2,236,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2025-01-01 to 2025-03-31

15,953,000
Source

10-K · 2026-03-12 · 0001933414-26-000056

2025-01-01 to 2025-12-31

14,593,000
Source

10-K · 2025-02-12 · 0001933414-25-000009

2024-01-01 to 2024-12-31

12,759,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

2023-01-01 to 2023-12-31

1,680,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

2022-01-01 to 2022-12-31

Operating ExpensesUSD——41,131,000
Source

10-Q · 2025-11-10 · 0001933414-25-000142

2025-07-01 to 2025-09-30

60,106,000
Source

10-Q · 2025-11-10 · 0001933414-25-000142

2024-07-01 to 2024-09-30

246,040,000
Source

10-Q · 2026-08-11 · 0001933414-26-000114

2026-04-01 to 2026-06-30

46,746,000
Source

10-Q · 2026-08-11 · 0001933414-26-000114

2025-04-01 to 2025-06-30

45,340,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2026-01-01 to 2026-03-31

44,447,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2025-01-01 to 2025-03-31

170,604,000
Source

10-K · 2026-03-12 · 0001933414-26-000056

2025-01-01 to 2025-12-31

192,403,000
Source

10-K · 2025-02-12 · 0001933414-25-000009

2024-01-01 to 2024-12-31

84,657,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

2023-01-01 to 2023-12-31

31,479,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

2022-01-01 to 2022-12-31

Other Nonoperating Income (Expense)USD——4,000
Source

10-Q · 2025-11-10 · 0001933414-25-000142

2025-07-01 to 2025-09-30

-10,000
Source

10-Q · 2025-11-10 · 0001933414-25-000142

2024-07-01 to 2024-09-30

13,000
Source

10-Q · 2026-08-11 · 0001933414-26-000114

2026-04-01 to 2026-06-30

-2,000
Source

10-Q · 2026-08-11 · 0001933414-26-000114

2025-04-01 to 2025-06-30

5,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2026-01-01 to 2026-03-31

-3,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2025-01-01 to 2025-03-31

0
Source

10-K · 2026-03-12 · 0001933414-26-000056

2025-01-01 to 2025-12-31

5,000
Source

10-K · 2025-02-12 · 0001933414-25-000009

2024-01-01 to 2024-12-31

——
Proceeds from Stock Options ExercisedUSD——————4,055,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2026-01-01 to 2026-03-31

123,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2025-01-01 to 2025-03-31

12,786,000
Source

10-K · 2026-03-12 · 0001933414-26-000056

2025-01-01 to 2025-12-31

297,000
Source

10-K · 2025-02-12 · 0001933414-25-000009

2024-01-01 to 2024-12-31

194,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

2023-01-01 to 2023-12-31

0
Source

10-K · 2024-03-21 · 0001628280-24-012358

2022-01-01 to 2022-12-31

Proceeds from Issuance of Common Stock————————
Source

10-Q · 2025-05-12 · 0001933414-25-000058

2025-01-01 to 2025-03-31

————

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements
Line itemQ4 2025Q4 2024Q3 2025Q3 2024Q2 2026Q2 2025Q1 2026Q1 2025FY 2025FY 2024FY 2023FY 2022
Operating Income (Loss)USD——-41,131,000
Source

10-Q · 2025-11-10 · 0001933414-25-000142

2025-07-01 to 2025-09-30

-60,106,000
Source

10-Q · 2025-11-10 · 0001933414-25-000142

2024-07-01 to 2024-09-30

-246,040,000
Source

10-Q · 2026-08-11 · 0001933414-26-000114

2026-04-01 to 2026-06-30

-46,746,000
Source

10-Q · 2026-08-11 · 0001933414-26-000114

2025-04-01 to 2025-06-30

-45,340,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2026-01-01 to 2026-03-31

-44,447,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2025-01-01 to 2025-03-31

-170,604,000
Source

10-K · 2026-03-12 · 0001933414-26-000056

2025-01-01 to 2025-12-31

-192,403,000
Source

10-K · 2025-02-12 · 0001933414-25-000009

2024-01-01 to 2024-12-31

-84,657,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

2023-01-01 to 2023-12-31

-31,479,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

2022-01-01 to 2022-12-31

Other Nonoperating Income (Expense)USD——4,000
Source

10-Q · 2025-11-10 · 0001933414-25-000142

2025-07-01 to 2025-09-30

-10,000
Source

10-Q · 2025-11-10 · 0001933414-25-000142

2024-07-01 to 2024-09-30

13,000
Source

10-Q · 2026-08-11 · 0001933414-26-000114

2026-04-01 to 2026-06-30

-2,000
Source

10-Q · 2026-08-11 · 0001933414-26-000114

2025-04-01 to 2025-06-30

5,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2026-01-01 to 2026-03-31

-3,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2025-01-01 to 2025-03-31

0
Source

10-K · 2026-03-12 · 0001933414-26-000056

2025-01-01 to 2025-12-31

5,000
Source

10-K · 2025-02-12 · 0001933414-25-000009

2024-01-01 to 2024-12-31

——
Income Tax Expense (Benefit)USD————————0
Source

10-K · 2026-03-12 · 0001933414-26-000056

2025-01-01 to 2025-12-31

———
Net Income (Loss) Attributable to ParentUSD——-36,932,000
Source

10-Q · 2025-11-10 · 0001933414-25-000142

2025-07-01 to 2025-09-30

-56,342,000
Source

10-Q · 2025-11-10 · 0001933414-25-000142

2024-07-01 to 2024-09-30

-241,071,000
Source

10-Q · 2026-08-11 · 0001933414-26-000114

2026-04-01 to 2026-06-30

-43,274,000
Source

10-Q · 2026-08-11 · 0001933414-26-000114

2025-04-01 to 2025-06-30

-39,339,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2026-01-01 to 2026-03-31

-42,211,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2025-01-01 to 2025-03-31

-154,651,000
Source

10-K · 2026-03-12 · 0001933414-26-000056

2025-01-01 to 2025-12-31

-177,810,000
Source

10-K · 2025-02-12 · 0001933414-25-000009

2024-01-01 to 2024-12-31

-71,898,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

2023-01-01 to 2023-12-31

-29,799,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

2022-01-01 to 2022-12-31

Earnings Per Share, BasicUSD per share——-0.52
Source

10-Q · 2025-11-10 · 0001933414-25-000142

2025-07-01 to 2025-09-30

-1.13
Source

10-Q · 2025-11-10 · 0001933414-25-000142

2024-07-01 to 2024-09-30

-2.85
Source

10-Q · 2026-08-11 · 0001933414-26-000114

2026-04-01 to 2026-06-30

-0.66
Source

10-Q · 2026-08-11 · 0001933414-26-000114

2025-04-01 to 2025-06-30

-0.47
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2026-01-01 to 2026-03-31

-0.79
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2025-01-01 to 2025-03-31

-2.29
Source

10-K · 2026-03-12 · 0001933414-26-000056

2025-01-01 to 2025-12-31

-3.66
Source

10-K · 2025-02-12 · 0001933414-25-000009

2024-01-01 to 2024-12-31

-1.99
Source

10-K · 2024-03-21 · 0001628280-24-012358

2023-01-01 to 2023-12-31

-5.77
Source

10-K · 2024-03-21 · 0001628280-24-012358

2022-01-01 to 2022-12-31

Earnings Per Share, DilutedUSD per share——-0.52
Source

10-Q · 2025-11-10 · 0001933414-25-000142

2025-07-01 to 2025-09-30

-1.13
Source

10-Q · 2025-11-10 · 0001933414-25-000142

2024-07-01 to 2024-09-30

-2.85
Source

10-Q · 2026-08-11 · 0001933414-26-000114

2026-04-01 to 2026-06-30

-0.66
Source

10-Q · 2026-08-11 · 0001933414-26-000114

2025-04-01 to 2025-06-30

-0.47
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2026-01-01 to 2026-03-31

-0.79
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2025-01-01 to 2025-03-31

-2.29
Source

10-K · 2026-03-12 · 0001933414-26-000056

2025-01-01 to 2025-12-31

-3.66
Source

10-K · 2025-02-12 · 0001933414-25-000009

2024-01-01 to 2024-12-31

-1.99
Source

10-K · 2024-03-21 · 0001628280-24-012358

2023-01-01 to 2023-12-31

-5.77
Source

10-K · 2024-03-21 · 0001628280-24-012358

2022-01-01 to 2022-12-31

Weighted Average Number of Shares Outstanding, Basicshares——70,594,504
Source

10-Q · 2025-11-10 · 0001933414-25-000142

2025-07-01 to 2025-09-30

49,815,186
Source

10-Q · 2025-11-10 · 0001933414-25-000142

2024-07-01 to 2024-09-30

84,727,282
Source

10-Q · 2026-08-11 · 0001933414-26-000114

2026-04-01 to 2026-06-30

65,451,297
Source

10-Q · 2026-08-11 · 0001933414-26-000114

2025-04-01 to 2025-06-30

82,834,752
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2026-01-01 to 2026-03-31

53,163,551
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2025-01-01 to 2025-03-31

67,656,355
Source

10-K · 2026-03-12 · 0001933414-26-000056

2025-01-01 to 2025-12-31

48,539,795
Source

10-K · 2025-02-12 · 0001933414-25-000009

2024-01-01 to 2024-12-31

36,188,254
Source

10-K · 2024-03-21 · 0001628280-24-012358

2023-01-01 to 2023-12-31

5,167,296
Source

10-K · 2024-03-21 · 0001628280-24-012358

2022-01-01 to 2022-12-31

Weighted Average Number of Shares Outstanding, Dilutedshares——70,594,504
Source

10-Q · 2025-11-10 · 0001933414-25-000142

2025-07-01 to 2025-09-30

49,815,186
Source

10-Q · 2025-11-10 · 0001933414-25-000142

2024-07-01 to 2024-09-30

84,727,282
Source

10-Q · 2026-08-11 · 0001933414-26-000114

2026-04-01 to 2026-06-30

65,451,297
Source

10-Q · 2026-08-11 · 0001933414-26-000114

2025-04-01 to 2025-06-30

82,834,752
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2026-01-01 to 2026-03-31

53,163,551
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2025-01-01 to 2025-03-31

67,656,355
Source

10-K · 2026-03-12 · 0001933414-26-000056

2025-01-01 to 2025-12-31

48,539,795
Source

10-K · 2025-02-12 · 0001933414-25-000009

2024-01-01 to 2024-12-31

36,188,254
Source

10-K · 2024-03-21 · 0001628280-24-012358

2023-01-01 to 2023-12-31

5,167,296
Source

10-K · 2024-03-21 · 0001628280-24-012358

2022-01-01 to 2022-12-31

Additional Financial Items
Current Income Tax Expense (Benefit)USD————————0
Source

10-K · 2026-03-12 · 0001933414-26-000056

2025-01-01 to 2025-12-31

0
Source

10-K · 2025-02-12 · 0001933414-25-000009

2024-01-01 to 2024-12-31

0
Source

10-K · 2024-03-21 · 0001628280-24-012358

2023-01-01 to 2023-12-31

0
Source

10-K · 2024-03-21 · 0001628280-24-012358

2022-01-01 to 2022-12-31

General and Administrative ExpenseUSD——9,681,000
Source

10-Q · 2025-11-10 · 0001933414-25-000142

2025-07-01 to 2025-09-30

6,121,000
Source

10-Q · 2025-11-10 · 0001933414-25-000142

2024-07-01 to 2024-09-30

24,663,000
Source

10-Q · 2026-08-11 · 0001933414-26-000114

2026-04-01 to 2026-06-30

8,468,000
Source

10-Q · 2026-08-11 · 0001933414-26-000114

2025-04-01 to 2025-06-30

20,975,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2026-01-01 to 2026-03-31

6,568,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2025-01-01 to 2025-03-31

38,595,000
Source

10-K · 2026-03-12 · 0001933414-26-000056

2025-01-01 to 2025-12-31

23,822,000
Source

10-K · 2025-02-12 · 0001933414-25-000009

2024-01-01 to 2024-12-31

14,296,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

2023-01-01 to 2023-12-31

5,229,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

2022-01-01 to 2022-12-31

Interest Income (Expense), Nonoperating, NetUSD——4,195,000
Source

10-Q · 2025-11-10 · 0001933414-25-000142

2025-07-01 to 2025-09-30

3,774,000
Source

10-Q · 2025-11-10 · 0001933414-25-000142

2024-07-01 to 2024-09-30

4,956,000
Source

10-Q · 2026-08-11 · 0001933414-26-000114

2026-04-01 to 2026-06-30

3,474,000
Source

10-Q · 2026-08-11 · 0001933414-26-000114

2025-04-01 to 2025-06-30

5,996,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2026-01-01 to 2026-03-31

2,239,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2025-01-01 to 2025-03-31

15,953,000
Source

10-K · 2026-03-12 · 0001933414-26-000056

2025-01-01 to 2025-12-31

14,588,000
Source

10-K · 2025-02-12 · 0001933414-25-000009

2024-01-01 to 2024-12-31

12,756,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

2023-01-01 to 2023-12-31

1,676,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

2022-01-01 to 2022-12-31

Nonoperating Income (Expense)USD——4,199,000
Source

10-Q · 2025-11-10 · 0001933414-25-000142

2025-07-01 to 2025-09-30

3,764,000
Source

10-Q · 2025-11-10 · 0001933414-25-000142

2024-07-01 to 2024-09-30

4,969,000
Source

10-Q · 2026-08-11 · 0001933414-26-000114

2026-04-01 to 2026-06-30

3,472,000
Source

10-Q · 2026-08-11 · 0001933414-26-000114

2025-04-01 to 2025-06-30

6,001,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2026-01-01 to 2026-03-31

2,236,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2025-01-01 to 2025-03-31

15,953,000
Source

10-K · 2026-03-12 · 0001933414-26-000056

2025-01-01 to 2025-12-31

14,593,000
Source

10-K · 2025-02-12 · 0001933414-25-000009

2024-01-01 to 2024-12-31

12,759,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

2023-01-01 to 2023-12-31

1,680,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

2022-01-01 to 2022-12-31

Operating ExpensesUSD——41,131,000
Source

10-Q · 2025-11-10 · 0001933414-25-000142

2025-07-01 to 2025-09-30

60,106,000
Source

10-Q · 2025-11-10 · 0001933414-25-000142

2024-07-01 to 2024-09-30

246,040,000
Source

10-Q · 2026-08-11 · 0001933414-26-000114

2026-04-01 to 2026-06-30

46,746,000
Source

10-Q · 2026-08-11 · 0001933414-26-000114

2025-04-01 to 2025-06-30

45,340,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2026-01-01 to 2026-03-31

44,447,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2025-01-01 to 2025-03-31

170,604,000
Source

10-K · 2026-03-12 · 0001933414-26-000056

2025-01-01 to 2025-12-31

192,403,000
Source

10-K · 2025-02-12 · 0001933414-25-000009

2024-01-01 to 2024-12-31

84,657,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

2023-01-01 to 2023-12-31

31,479,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

2022-01-01 to 2022-12-31

Research and Development ExpenseUSD——31,450,000
Source

10-Q · 2025-11-10 · 0001933414-25-000142

2025-07-01 to 2025-09-30

53,985,000
Source

10-Q · 2025-11-10 · 0001933414-25-000142

2024-07-01 to 2024-09-30

221,377,000
Source

10-Q · 2026-08-11 · 0001933414-26-000114

2026-04-01 to 2026-06-30

38,278,000
Source

10-Q · 2026-08-11 · 0001933414-26-000114

2025-04-01 to 2025-06-30

24,365,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2026-01-01 to 2026-03-31

37,879,000
Source

10-Q · 2026-05-06 · 0001933414-26-000084

2025-01-01 to 2025-03-31

132,009,000
Source

10-K · 2026-03-12 · 0001933414-26-000056

2025-01-01 to 2025-12-31

168,581,000
Source

10-K · 2025-02-12 · 0001933414-25-000009

2024-01-01 to 2024-12-31

70,361,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

2023-01-01 to 2023-12-31

26,250,000
Source

10-K · 2024-03-21 · 0001628280-24-012358

2022-01-01 to 2022-12-31

Lines labelled “Derived” are calculated from reported figures.

Filing attachments

mlys2026q38kex991.htm · 8-K · 2026-11-04

Exhibit 99.1 Mineralys Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update - Commercialization plans for lorundrostat are on track ahead of PDUFA target date of December 22, 2026 - - New analyses from the pivotal Launch-HTN trial showed 46% of participants with uncontrolled or resistant hypertension receiving lorundrostat 50 mg achieved the AHA/ACC guideline systolic blood pressure target of <130 mmHg at Week 12 - - Transform-HTN open-label extension trial…

8-K · 2026-11-04 · 0001933414-26-000142

Read attachment ↗
mlys2026q28kex991.htm · 8-K · 2026-08-11

EX-99.1 3 mlys2026q28kex991.htm EX-99.1 Document Exhibit 99.1 Mineralys Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update - PDUFA target date of December 22, 2026 for lorundrostat; commercial preparations on-track for launch upon approval - - Appoints accomplished cardiovascular medicine executive Dr. Terry Ferguson as Chief Medical Officer to lead the Company’s medical and late-stage clinical activities - - Strengthened balance sheet and enhanced …

8-K · 2026-08-11 · 0001933414-26-000112

Read attachment ↗
mlys2026q18kex991.htm · 8-K · 2026-05-06

EX-99.1 2 mlys2026q18kex991.htm EX-99.1 Document Exhibit 99.1 Mineralys Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update - NDA for lorundrostat in adults with hypertension accepted by FDA; assigned PDUFA target date of December 22, 2026 - - Conference call today at 4:30 p.m. ET - RADNOR, PA - May 6, 2026 - Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and related como…

8-K · 2026-05-06 · 0001933414-26-000082

Read attachment ↗
mlys202601068kex991.htm · 8-K · 2026-01-06

Exhibit 99.1 Mineralys Therapeutics Provides Corporate Update and Announces Participation in Upcoming LifeSci Partners Corporate Access Event in January 2026 RADNOR, PA - January 6, 2026 - Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone, today issued a co…

8-K · 2026-01-06 · 0001933414-26-000002

Read attachment ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.